These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2239366)

  • 21. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
    Stolz DB; Michalopoulos GK
    J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
    Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
    J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH
    J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta 1 is chemotactic for interleukin-2-activated natural killer cells.
    Maghazachi AA; al-Aoukaty A
    Nat Immun; 1993; 12(2):57-65. PubMed ID: 8318816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of transforming growth factor beta on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells.
    Seitz PK; Zhu BT; Cooper CW
    J Bone Miner Res; 1992 May; 7(5):541-6. PubMed ID: 1319667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of intermittent compressive force on transforming growth factor beta and osteopontin synthesis in cultured bone cells].
    Yamauchi M
    Kanagawa Shigaku; 1990 Mar; 24(4):716-29. PubMed ID: 2133741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.
    Phan SH; Gharaee-Kermani M; McGarry B; Kunkel SL; Wolber FW
    J Immunol; 1992 Jul; 149(1):103-6. PubMed ID: 1376744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of transforming growth factor-beta in bone remodeling.
    Bonewald LF; Mundy GR
    Clin Orthop Relat Res; 1990 Jan; (250):261-76. PubMed ID: 2403492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells.
    Agarwal C; Hembree JR; Rorke EA; Eckert RL
    Cancer Res; 1994 Feb; 54(4):943-9. PubMed ID: 8313385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1.
    Soma Y; Mizoguchi M; Yamane K; Yazawa N; Kubo M; Ihn H; Kikuchi K; Tamaki K
    Arch Dermatol Res; 2002 Feb; 293(12):609-13. PubMed ID: 11875643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of TGF-beta on bone.
    Mundy GR
    Ciba Found Symp; 1991; 157():137-43; discussion 143-51. PubMed ID: 2070682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta.
    De Simone R; Ambrosini E; Carnevale D; Ajmone-Cat MA; Minghetti L
    J Neuroimmunol; 2007 Oct; 190(1-2):53-60. PubMed ID: 17868907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor beta-1.
    Fortier LA; Nixon AJ; Mohammed HO; Lust G
    Am J Vet Res; 1997 Jan; 58(1):66-70. PubMed ID: 8989499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study.
    Ramirez-Yañez GO; Hamlet S; Jonarta A; Seymour GJ; Symons AL
    Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):183-92. PubMed ID: 16504491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells.
    Ghayor C; Rey A; Caverzasio J
    Bone; 2005 Jan; 36(1):93-100. PubMed ID: 15664007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotactic response of osteoblast-like cells to transforming growth factor beta.
    Lucas PA
    Bone; 1989; 10(6):459-63. PubMed ID: 2624828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-passage rat lung fibroblasts do not migrate in vitro to transforming growth factor-beta.
    Osornio-Vargas AR; Kalter VG; Badgett A; Hernández-Rodríguez N; Aguilar-Delfín I; Brody AR
    Am J Respir Cell Mol Biol; 1993 May; 8(5):468-71. PubMed ID: 8481230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta.
    Hughes FJ; Aubin JE; Heersche JN
    Bone Miner; 1992 Oct; 19(1):63-74. PubMed ID: 1422306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria.
    Panagakos FS
    Biochimie; 1993; 75(11):991-4. PubMed ID: 8123707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro chemotactic response of osteoblast-like osteosarcoma cells to a partially purified protein extract of demineralized bone matrix.
    Padley RA; Cobb CM; Killoy WJ; Newhouse NL; Boyan BD
    J Periodontol; 1991 Jan; 62(1):15-20. PubMed ID: 2002426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.